Position in TGTX
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$962,768
+$643,560 QoQ
Shares Held
17,524
-17.4% QoQ
Ownership
0.011%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#193
of 420 holders
Holding Since
Jun 2020
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in TGTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Virtu Financial LLC holds $37,860,153 across 147 Biotechnology names. TGTX ranks #7 (2.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TECH |
BIO-TECHNE Corp
|
58,459 | $4,130,128 | |
| 2 | APGE |
Apogee Therapeutics, Inc.
|
29,790 | $3,954,026 | |
| 3 | ABVX |
Abivax S.A.
|
19,155 | $2,552,595 | |
| 4 | AXSM |
Axsome Therapeutics, Inc.
|
9,220 | $2,256,779 | |
| 5 | KYMR |
Kymera Therapeutics, Inc.
|
12,556 | $1,439,796 | |
| 6 | PTGX |
Protagonist Therapeutics, Inc
|
8,163 | $1,000,620 | |
| 7 | TGTX |
Tg Therapeutics, Inc.
This page
|
17,524 | $962,768 | |
| 8 | IOVA |
Iovance Biotherapeutics, Inc.
|
221,500 | $921,440 |
All Filings in TGTX
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $962,768 | 17,524 | Shares | Defined | 2026-08-13 | |
| 2023-03-31 | $319,208 | 21,224 | Shares | Defined | 2023-05-01 | |
| 2022-06-30 | $51,811 | 12,191 | Shares | Defined | 2022-08-09 | |
| 2022-03-31 | $195,573 | 20,565 | Shares | Defined | 2022-05-17 | |
| 2021-06-30 | $251,863 | 6,493 | Shares | Defined | 2021-09-17 | |
| 2020-12-31 | $901,506 | 17,330 | Shares | Defined | 2021-02-24 | |
| 2020-06-30 | $204,091 | 10,477 | Shares | Defined | 2020-08-07 | |
| No filing history on record for this holder in this stock. | ||||||